Related Experiment Videos
Dopamine receptor subtypes and formalin test analgesia.
1Department of Psychology, McGill University, Montreal, Quebec, Canada.
Pharmacology, Biochemistry, and Behavior
|October 1, 1991
Summary
Dopamine D1 and D2 receptors influence pain relief. D1 receptors enable D2 receptor-mediated analgesia in the formalin test, impacting pain management strategies.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Dopamine receptors, specifically D1 and D2 subtypes, are implicated in modulating pain perception.
- The formalin test is a widely used animal model to study analgesic effects.
Purpose of the Study:
- To elucidate the specific roles of dopamine D1 and D2 receptors in analgesia within the formalin test.
- To investigate how selective and mixed dopamine receptor agonists and antagonists affect pain responses.
Main Methods:
- Administering mixed and selective D1/D2 dopamine receptor antagonists (cis-flupenthixol, pimozide, SCH 23390) to challenge D-amphetamine and morphine analgesia.
- Evaluating the analgesic efficacy of mixed (apomorphine) and selective (quinpirole, SKF 38393) dopamine receptor agonists.
Main Results:
- Mixed D1/D2, D2, and D1 antagonists significantly attenuated D-amphetamine and morphine-induced analgesia.
- Mixed D1/D2 and selective D2 agonists demonstrated dose-dependent analgesic effects.
- Selective D1 agonists did not produce analgesia in this model.
Conclusions:
- Dopamine D2 receptors are directly involved in mediating analgesia in the formalin test.
- Dopamine D1 receptors appear to play a crucial 'enabling' role, facilitating D2 receptor-dependent pain relief.